CLINICAL INVESTIGATIONS OF CS-1170 IN SURGICAL FIELD

1. Consecutive transfer of CS-1170 in bile was investigated on 2 groups of patients, the one with disorder of hepatic function and the other without these disorders. 2. In the group of normal hepatic function, concentrations of the drug showed a peak of more than 20 μg/ml after 1 g drip infusion, wh...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 26; no. Supplement5; pp. 430 - 434
Main Author NISHIKATA, FUJIHIKO
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1978
Online AccessGet full text

Cover

Loading…
More Information
Summary:1. Consecutive transfer of CS-1170 in bile was investigated on 2 groups of patients, the one with disorder of hepatic function and the other without these disorders. 2. In the group of normal hepatic function, concentrations of the drug showed a peak of more than 20 μg/ml after 1 g drip infusion, while a peak of 35.5 μg/ml after 2 g drip infusion. 3. In the group of disordered hepatic function, scattering was noticed from 4.2 μg/ml to 2 μg/ml after 1 g drip infusion. 4. CS-1170 was drip infused to 5 cases of biliary tract infection at a daily dose of 4 g divided into 2 times, and the results obtained were remarkably effective in 3 cases, effective in 1 case and ineffective in 1 case. No side effect was observed with the drug throughout all cases.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.26.Supplement5_430